{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:47:38Z","timestamp":1789660058092,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE4045\/34-1"],"award-info":[{"award-number":["BE4045\/34-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030L_179450"],"award-info":[{"award-number":["320030L_179450"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bpsc.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T12:47:52Z","timestamp":1677415672000},"page":"956-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-6859","authenticated-orcid":false,"given":"Rebecca C.","family":"Coray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatta","family":"Berberat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josua","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Unschuld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris B.","family":"Quednow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsc.2023.02.005_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hup.2318","article-title":"Human psychobiology of MDMA or \u201cEcstasy\u201d: An overview of 25 years of empirical research","volume":"28","author":"Parrott","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.bpsc.2023.02.005_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neubiorev.2018.11.004","article-title":"Neuroimaging of chronic MDMA (\u201cecstasy\u201d) effects: A meta-analysis","volume":"96","author":"M\u00fcller","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/npp.2012.178","article-title":"Brain serotonin function in MDMA (ecstasy) users: Evidence for persisting neurotoxicity","volume":"38","author":"M Benningfield","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/JCP.0000000000000962","article-title":"Methylenedioxymethamphetamine (MDMA) in psychiatry: Pros, cons, and suggestions","volume":"38","author":"Schenk","year":"2018","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-006-0601-2","article-title":"MDMA use and neurocognition: A meta-analytic review","volume":"189","author":"Kalechstein","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11065-009-9124-z","article-title":"Differential effects of ecstasy on short-term and working memory: A meta-analysis","volume":"20","author":"Nulsen","year":"2010","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113888","article-title":"Neurological and cognitive alterations induced by MDMA in humans","volume":"347","author":"Montgomery","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hup.1270","article-title":"The effects of \u2018ecstasy\u2019 (MDMA) on visuospatial memory performance: Findings from a systematic review with meta-analyses","volume":"27","author":"Murphy","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269881106061200","article-title":"Memory deficits in abstinent MDMA (ecstasy) users: Neuropsychological evidence of frontal dysfunction","volume":"20","author":"Quednow","year":"2006","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.euroneuro.2017.08.425","article-title":"Discrete memory impairments in largely pure chronic users of MDMA","volume":"27","author":"Wunderli","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ejn.13480","article-title":"Decision-making in chronic ecstasy users: A systematic review","volume":"45","author":"Betzler","year":"2017","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-7843.2007.00159.x","article-title":"The dark side of ecstasy: Neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine","volume":"102","author":"Karlsen","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130000545","article-title":"Ecstasy (MDMA): A review of its possible persistent psychological effects","volume":"152","author":"Morgan","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neubiorev.2016.02.003","article-title":"Meta-analysis of molecular imaging of serotonin transporters in ecstasy\/polydrug users","volume":"63","author":"Roberts","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-0173(03)00173-5","article-title":"Methylenedioxymethamphetamine (MDMA, ecstasy) neurotoxicity: Cellular and molecular mechanisms","volume":"42","author":"Lyles","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib17","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","article-title":"Altered serotonin innervation patterns in the forebrain of monkeys treated with (+\/\u2212)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery","volume":"19","author":"Hatzidimitriou","year":"1999","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib18","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1523\/JNEUROSCI.15-08-05476.1995","article-title":"Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+\/-) 3, 4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"15","author":"Fischer","year":"1995","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1749-6632.1990.tb16918.x","article-title":"Neurotoxic effect of MDMA on brain serotonin neurons: Evidence from neurochemical and radioligand binding studies","volume":"600","author":"de Souza","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s002130050057","article-title":"Memory disturbances in \u201dEcstasy\u201d users are correlated with an altered brain serotonin neurotransmission","volume":"148","author":"Reneman","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1360-0443.2006.01314.x","article-title":"Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: How strong is the evidence for persistent brain damage?","volume":"101","author":"Gouzoulis-Mayfrank","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.bpsc.2023.02.005_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000026665","article-title":"(+\/-)3,4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019)-induced serotonin neurotoxicity: Clinical studies","volume":"42","author":"McCann","year":"2000","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2003.07.001","article-title":"Reduced cortical gray matter density in human MDMA (Ecstasy) users: A voxel-based morphometry study","volume":"72","author":"Cowan","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsc.2023.02.005_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2811","article-title":"Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3, 4-methylenedioxymethamphetamine users","volume":"37","author":"van de Blaak","year":"2022","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.bpsc.2023.02.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113894","article-title":"Neurotoxicity of MDMA: Main effects and mechanisms","volume":"347","author":"Costa","year":"2022","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11481-008-9121-7","article-title":"The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse","volume":"3","author":"Yamamoto","year":"2008","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib27","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1021\/acs.jproteome.8b00438","article-title":"Human metabolome changes after a single dose of 3,4-methylenedioxymethamphetamine (MDMA) with special focus on steroid metabolism and inflammation processes","volume":"17","author":"Boxler","year":"2018","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.bpsc.2023.02.005_bib28","first-page":"31","article-title":"Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites","volume":"53","author":"Macedo","year":"2007","journal-title":"J\u00a0Heal Sci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib29","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.18-18-07111.1998","article-title":"Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: Possible endogenous toxin to serotonin neurons","volume":"18","author":"Kuhn","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib30","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1002\/anie.201811122","article-title":"Dopamine, oxidative stress and protein\u2013quinone modifications in Parkinson\u2019s and other neurodegenerative diseases","volume":"58","author":"Monzani","year":"2019","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bpsc.2023.02.005_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2013.05.042","article-title":"Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease\u2014Resemblance to the effect of amphetamine drugs of abuse","volume":"62","author":"Perfeito","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.618435","article-title":"Systematic review: Quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases","volume":"15","author":"Ravanfar","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11065-015-9292-y","article-title":"Appraising the role of iron in brain aging and cognition: Promises and limitations of MRI methods","volume":"25","author":"Daugherty","year":"2015","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118267","article-title":"Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging","volume":"239","author":"Khattar","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.bpsc.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hbm.25706","article-title":"Cortical iron mediates age-related decline in fluid cognition","volume":"43","author":"Howard","year":"2022","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.bpsc.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/1673-5374.358614","article-title":"Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration","volume":"18","author":"Villal\u00f3n-Garc\u00eda","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.bpsc.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/WNR.0b013e3282f0d4f4","article-title":"Methamphetamine increases basal ganglia iron to levels observed in aging","volume":"18","author":"Melega","year":"2007","journal-title":"NeuroReport"},{"key":"10.1016\/j.bpsc.2023.02.005_bib38","first-page":"579","article-title":"Elevated brain Iron in cocaine use disorder as indexed by magnetic field correlation imaging","volume":"4","author":"Adisetiyo","year":"2019","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.bpsc.2023.02.005_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.271","article-title":"Disrupted iron regulation in the brain and periphery in cocaine addiction","volume":"7","author":"Ersche","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsc.2023.02.005_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162460","article-title":"Quantitative susceptibility mapping in Parkinson\u2019s disease","volume":"11","author":"Langkammer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bpsc.2023.02.005_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau9940","article-title":"Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection","volume":"5","author":"Daruich","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.bpsc.2023.02.005_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1326-9-27","article-title":"Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: Implications for Parkinson\u2019s disease","volume":"9","author":"Ayton","year":"2014","journal-title":"Mol Neurodegeneration"},{"key":"10.1016\/j.bpsc.2023.02.005_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neurobiolaging.2016.04.002","article-title":"Determinants of iron accumulation in the normal aging brain","volume":"43","author":"Pirpamer","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bpsc.2023.02.005_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103191","article-title":"White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels","volume":"36","author":"Zimmermann","year":"2022","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.bpsc.2023.02.005_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaac.2022.11.011","article-title":"When substance use is underreported: Comparing self-reports and hair toxicology in an urban cohort of young adults","volume":"62","author":"Steinhoff","year":"2023","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.bpsc.2023.02.005_bib46","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.bpsc.2023.02.005_bib47","series-title":"The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Instruments for Adults","first-page":"363","article-title":"Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R)","author":"Eaton","year":"2004"},{"key":"10.1016\/j.bpsc.2023.02.005_bib48","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00115-003-1622-2","article-title":"Tools for the diagnosis of attention-deficit\/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist","volume":"75","author":"R\u00f6sler","year":"2004","journal-title":"Nervenarzt"},{"key":"10.1016\/j.bpsc.2023.02.005_bib49","series-title":"The Encyclopedia of Clinical Psychology","first-page":"1","article-title":"Structured clinical interview for the DSM (SCID)","author":"First","year":"2014"},{"key":"10.1016\/j.bpsc.2023.02.005_bib50","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.npp.1300396","article-title":"Prepulse inhibition and habituation of acoustic startle response in male MDMA (\u2018ecstasy\u2019) users, cannabis users, and healthy controls","volume":"29","author":"Quednow","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jat\/bkaa131","article-title":"A\u00a0comprehensive multi-analyte method for hair analysis: Substance-specific quantification ranges and tool for task-oriented data evaluation","volume":"45","author":"Scholz","year":"2021","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib52","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mrm.29048","article-title":"QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping","volume":"87","author":"Stewart","year":"2022","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bpsc.2023.02.005_bib54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fninf.2016.00035","article-title":"MINC 2.0: A flexible format for multi-modal images","volume":"10","author":"Vincent","year":"2016","journal-title":"Front Neuroinform"},{"key":"10.1016\/j.bpsc.2023.02.005_bib55","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.bpsc.2023.02.005_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnins.2012.00171","article-title":"101 labeled brain images and a consistent human cortical labeling protocol","volume":"6","author":"Klein","year":"2012","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.bpsc.2023.02.005_bib58","series-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2021"},{"key":"10.1016\/j.bpsc.2023.02.005_bib59","first-page":"285","article-title":"Robust statistics: A survey and some prescriptions","volume":"1","author":"Wainer","year":"1976","journal-title":"J\u00a0Educ Stat"},{"key":"10.1016\/j.bpsc.2023.02.005_bib60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc B"},{"key":"10.1016\/j.bpsc.2023.02.005_bib61","unstructured":"Fox J, Weisberg S (2011): An {R} Companion to Applied Regression, Second Edition. Thousand Oaks CA: Sage. Available at: http:\/\/socserv.socsci.mcmaster.ca\/jfox\/Books\/Companionhttp:\/\/cran.nexr.com\/web\/packages\/car\/citation.html."},{"key":"10.1016\/j.bpsc.2023.02.005_bib62","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.21105\/joss.03139","article-title":"performance: An R package for assessment, comparison and testing of statistical models","volume":"6","author":"L\u00fcdecke","year":"2021","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.bpsc.2023.02.005_bib63","series-title":"Package \u2018StepReg.\u2019","author":"Li","year":"2020"},{"key":"10.1016\/j.bpsc.2023.02.005_bib64","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3565(25)09490-X","article-title":"The monoamine oxidase-B inhibitor L-deprenyl protects against 3, 4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits","volume":"273","author":"Sprague","year":"1995","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bpsc.2023.02.005_bib65","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.neuroscience.2007.03.028","article-title":"Neurotoxicity mechanisms of thioether ecstasy metabolites","volume":"146","author":"Capela","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bpsc.2023.02.005_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphar.2014.00038","article-title":"The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders","volume":"5","author":"Urrutia","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib67","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bpsc.2023.02.005_bib68","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.3390\/ijms20194968","article-title":"Programmed cell-death by ferroptosis: Antioxidants as mitigators","volume":"20","author":"Kajarabille","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib69","article-title":"Mitochondria and ferroptosis","volume":"25","author":"Javadov","year":"2022","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(00)00264-8","article-title":"Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration","volume":"398","author":"Burrows","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib71","doi-asserted-by":"crossref","first-page":"28894","DOI":"10.1074\/jbc.M503090200","article-title":"Excitotoxic injury to mitochondria isolated from cultured neurons","volume":"280","author":"Kushnareva","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpsc.2023.02.005_bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2005.07.009","article-title":"Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT","volume":"1056","author":"Darvesh","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.bpsc.2023.02.005_bib73","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00018-013-1509-8","article-title":"Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration","volume":"71","author":"Andersen","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nicl.2017.08.019","article-title":"Quantitative susceptibility mapping to evaluate the early stage of Alzheimer\u2019s disease","volume":"16","author":"Kim","year":"2017","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.bpsc.2023.02.005_bib75","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/ern.13.14","article-title":"Iron accumulation in multiple sclerosis: An early pathogenic event","volume":"13","author":"LeVine","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bpsc.2023.02.005_bib76","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.msard.2013.06.017","article-title":"Increased deep gray matter iron is present in clinically isolated syndromes","volume":"3","author":"Quinn","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.bpsc.2023.02.005_bib77","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00702-021-02414-z","article-title":"Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson\u2019s disease","volume":"128","author":"Riederer","year":"2021","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.bpsc.2023.02.005_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88840-1","article-title":"Age-related iron accumulation and demyelination in the basal ganglia are closely related to verbal memory and executive functioning","volume":"11","author":"Biel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpsc.2023.02.005_bib79","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/cercor\/bhx045","article-title":"Higher striatal iron concentration is linked to frontostriatal underactivation and poorer memory in normal aging","volume":"27","author":"Kalpouzos","year":"2017","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.bpsc.2023.02.005_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116544","article-title":"Striatal iron content is linked to reduced fronto-striatal brain function under working memory load","volume":"210","author":"Rodrigue","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.bpsc.2023.02.005_bib81","series-title":"The Routledge International Handbook of Psychobiology","first-page":"331","article-title":"What is the evidence for psychobiological harm from the use of \u2018ecstasy\u2019 (MDMA)?","author":"Roberts","year":"2018"},{"key":"10.1016\/j.bpsc.2023.02.005_bib82","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1017\/S0033291716000258","article-title":"Meta-analysis of executive functioning in ecstasy\/polydrug users","volume":"46","author":"Roberts","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1874473711205030243","article-title":"Substance abuse and movement disorders: Complex interactions and comorbidities","volume":"5","author":"Deik","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.bpsc.2023.02.005_bib84","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mds.10643","article-title":"What is the evidence that Ecstasy (MDMA) can cause Parkinson\u2019s disease?","volume":"18","author":"Kish","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.bpsc.2023.02.005_bib85","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM199905063401817","article-title":"Parkinsonism after taking ecstasy","volume":"340","author":"Mintzer","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib86","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mds.10623","article-title":"Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs","volume":"18","author":"O\u2019Suilleabhain","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.bpsc.2023.02.005_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1056\/NEJMc030208","article-title":"MDMA and parkinsonism","volume":"349","author":"Kuniyoshi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpsc.2023.02.005_bib88","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1002\/hbm.22928","article-title":"Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping","volume":"36","author":"He","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.bpsc.2023.02.005_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113795","article-title":"Neurotoxicity of methamphetamine: Main effects and mechanisms","volume":"344","author":"Jayanthi","year":"2021","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib90","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.3390\/ijerph18094789","article-title":"Illicit drug use and associated problems in the nightlife scene: A potential setting for prevention","volume":"18","author":"Feltmann","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bpsc.2023.02.005_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-85389-x","article-title":"Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database","volume":"11","author":"Cohen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpsc.2023.02.005_bib92","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s12640-021-00416-z","article-title":"Hard boiled: Alcohol use as a risk factor for MDMA-induced hyperthermia: A systematic review","volume":"39","author":"van Amsterdam","year":"2021","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bpsc.2023.02.005_bib93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1369-1600.2010.00259.x","article-title":"Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats","volume":"15","author":"Hernandez-Rabaza","year":"2010","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00213-006-0602-1","article-title":"Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain","volume":"189","author":"Izco","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bpsc.2023.02.005_bib95","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1476-5381.2012.02065.x","article-title":"Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) and related psychostimulants: Mechanisms and mediators","volume":"167","author":"Vanattou-Sa\u00effoudine","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.0953-816X.2004.03453.x","article-title":"Brain hyperthermia induced by MDMA (\u2018ecstasy\u2019): Modulation by environmental conditions","volume":"20","author":"Brown","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0079-6123(06)62005-0","article-title":"Thermophysiological responses to hyperthermic drugs: Extrapolating from rodent to human","volume":"162","author":"Gordon","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.bpsc.2023.02.005_bib98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/23328940.2014.955433","article-title":"Effects of MDMA on body temperature in humans","volume":"1","author":"Liechti","year":"2014","journal-title":"Temperature"},{"key":"10.1016\/j.bpsc.2023.02.005_bib99","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","article-title":"Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat","volume":"18","author":"Malberg","year":"1998","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.bpsc.2023.02.005_bib100","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1476-5381.2012.01941.x","article-title":"MDMA and 5-HT neurotoxicity: The empirical evidence for its adverse effects in humans \u2013 no need for translation","volume":"166","author":"Parrott","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpsc.2023.02.005_bib101","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/23328940.2014.977182","article-title":"Saturday night fever in ecstasy\/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes","volume":"1","author":"Parrott","year":"2014","journal-title":"Temperature"}],"container-title":["Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902223000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451902223000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:21:25Z","timestamp":1762521685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451902223000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2451902223000435"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsc.2023.02.005","relation":{},"ISSN":["2451-9022"],"issn-type":[{"value":"2451-9022","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsc.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}